U.S. Insurance Stock News

NYSE:ORI
NYSE:ORIInsurance

Old Republic Fixed Income Deal And What It Means For Shareholders

Old Republic International (NYSE:ORI) has completed a substantial fixed-income offering, issuing new callable, senior, unsecured notes. The transaction adds fresh debt capital to the balance sheet, with terms structured around future call dates and interest payments. This funding move is designed to influence the company’s financial flexibility and long term funding mix. For investors tracking NYSE:ORI, the deal comes with the stock at $39.32 and a mixed return profile. Shares are up 11.4%...
NYSE:DAC
NYSE:DACShipping

Danaos Weighs Geopolitical Risks Against Fleet Growth And Valuation Potential

Danaos (NYSE:DAC) reports limited earnings impact from recent geopolitical disruptions, including the closure of the Strait of Hormuz, supported by long term charter coverage. The company is expanding its fleet in drybulk and LNG, adding Newcastlemax dry bulk carriers and 5,000 TEU containerships under new vessel orders. Contracted revenue backlog and additional energy sector investments point to a broader shift in how Danaos positions its shipping operations. For investors tracking...
NYSE:LOMA
NYSE:LOMABasic Materials

Loma Negra (LOMA) Reports Stronger Margins and Cash Flow: Is Its Profitability Story Shifting Gears?

Loma Negra Compañía Industrial Argentina Sociedad Anónima recently reported first-quarter 2026 results, with sales of ARS 218,739 million and net income of ARS 41,004 million, alongside higher earnings per share from continuing operations versus a year earlier. An interesting takeaway is that management credited a rebound in March cement activity and stronger margins for offsetting earlier industry softness and improving cash flow. Next, we’ll explore how this margin improvement and...
NYSE:WST
NYSE:WSTLife Sciences

West Pharmaceutical Cyberattack Tests Operational Resilience And Investor Risk Assumptions

West Pharmaceutical Services (NYSE:WST) reported a material cybersecurity incident involving data exfiltration and system encryption. The attack triggered a temporary suspension of global operations while the company worked to contain the breach. The full operational and financial impact remains uncertain as investigations and system restoration continue. West Pharmaceutical Services steps into this cyber event after a period of strong share price performance, with the stock up 40.3% over...
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

Canadian Solar Resets Focus On U.S. Manufacturing And Margin Quality

Canadian Solar (NasdaqGS: CSIQ) has appointed Colin Parkin as CEO, with founder Shawn Qu shifting to Executive Chairman and CTO. The company is reorienting its business toward value driven growth and profitability instead of pure volume expansion. Canadian Solar has begun trial production at its new HJT solar cell factory in Indiana and expanded module capacity in Texas to build out its U.S. manufacturing base. For you as an investor, this marks a key moment for one of the largest solar and...
NYSEAM:REI
NYSEAM:REIOil and Gas

Ring Energy (REI) Is Down 15.5% After Discounted Equity Raise To Pay Down Debt - What's Changed

Earlier this week, Ring Energy, Inc. completed a US$60.00 million follow-on common stock offering at US$1.35 per share, issuing 44,444,445 shares primarily to repay borrowings under its senior secured revolving credit facility. This capital raise follows a first-quarter 2026 net loss of US$220.59 million and coincides with expanded responsibilities for CFO Sundip “Sonu” S. Johl as Principal Financial Officer, underscoring management’s focus on balance sheet repair and financial...
NYSEAM:LGCY
NYSEAM:LGCYConsumer Services

Legacy Education (LGCY) Earnings Growth Story Faces Slight Margin Decline Narrative Test

Legacy Education (LGCY) has put fresh numbers on the table for Q3 2026, with recent quarterly revenue figures around US$19.4 million in Q1 2026 and US$19.2 million in Q2 2026, alongside basic EPS of US$0.18 and US$0.16 respectively. This sets the backdrop for its latest update at a share price of US$11.92. Over the past year, the company has seen total revenue move from US$52.7 million to US$75.1 million and trailing 12 month EPS lift from US$0.62 to US$0.66, giving investors a clear sense of...
NasdaqGS:HCKT
NasdaqGS:HCKTIT

Is Hackett Group’s AI Pivot With IBM and Capital Returns Reframing the HCKT Investment Story?

In early May 2026, The Hackett Group reported first-quarter 2026 results showing lower sales and revenue than a year earlier but higher net income and earnings per share, reaffirmed its US$0.12 quarterly dividend, detailed recent share repurchases under its long-running buyback, and filed a US$3.47 million ESOP-related common stock shelf registration. Ahead of its AI-focused transition and new global collaboration with IBM, Hackett also issued second-quarter 2026 revenue guidance and...
NasdaqGM:WRD
NasdaqGM:WRDAuto Components

WeRide’s Global Robotaxi Expansion Meets Depressed Valuation Expectations

WeRide (NasdaqGM:WRD) reports record Q1 2026 revenue, supported by expanded robotaxi and ADAS operations. The company launches fully driverless robotaxi services in Dubai, Abu Dhabi, and Singapore, growing its presence outside China. WeRide introduces its Genesis simulation platform, designed to speed up training of autonomous driving AI models. WRD 3.0 receives top honors in China's urban driving competitions, highlighting progress in complex city environments. For investors tracking...
NYSE:AVEX
NYSE:AVEXAerospace & Defense

Is It Time To Reassess AEVEX (AVEX) After Recent Share Price Weakness?

With AEVEX trading at US$24.87, you might be wondering whether the current price really lines up with what the stock could be worth based on fundamentals. Over the short term, the share price has been under some pressure, with the stock down 0.8% over the last week and down 7.6% year to date. This may be changing how the market views its risk and reward profile. Recent coverage of AEVEX has focused less on short term headlines and more on giving investors a consistent view of the company...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

CareDx Lawsuit Resolution Refocuses Attention On Valuation And Growth Prospects

CareDx (NasdaqGM:CDNA) disclosed that a long standing qui tam lawsuit has been dismissed. The company had previously announced that the Department of Justice closed a related investigation without findings of wrongdoing. Together, these outcomes remove a material legal overhang tied to historical compliance questions. CareDx focuses on transplant diagnostics and related services, an area where regulatory oversight and reimbursement policies are central to the business model. For investors...
NYSE:NSA
NYSE:NSASpecialized REITs

Is National Storage Affiliates (NSA) Fairly Priced After Its Strong Year To Date Rally?

Considering whether National Storage Affiliates Trust at around US$41.02 is offering fair value right now or if the price is out of line with the fundamentals. The stock is up 47.1% year to date and 20.2% over the past year, even though it has fallen 6.1% in the last week and 2.1% over the past month. Recent market attention has focused on how self storage REITs are positioned within real estate, as investors reassess income focused sectors and their sensitivity to interest rates. This...
NYSE:CRL
NYSE:CRLLife Sciences

Charles River Deepens Cell Therapy Role And Expands AI Pathology Platform

Charles River Laboratories International (NYSE:CRL) has entered into a partnership with MEDIPOST to support development and commercialization of cell therapies across Asia-Pacific and North America. The company is supplying biologics and GMP testing services to MEDIPOST’s global pipeline of regenerative medicine products. At the same time, Charles River introduced major upgrades to its digital pathology platform, adding AI-powered and fully digital workflows. The new digital pathology...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Assessing Paysign (PAYS) Valuation After Record Q1 Results And Patient Affordability Shift

Paysign (PAYS) is back in focus after reporting record first quarter 2026 results, with revenue of US$28.04 million and net income of US$5.44 million, while its patient affordability business became the largest contributor. See our latest analysis for Paysign. The share price has been volatile around these earnings, slipping 2.94% on the day and 9.65% over the past week. However, the 90 day share price return of 65.78% and 1 year total shareholder return of 55.89% still point to strong recent...
NYSE:SQM
NYSE:SQMChemicals

SQM Weighs Higher Dividend With New Codelco Lithium Joint Venture

Sociedad Química y Minera de Chile (NYSE:SQM) has proposed raising its final dividend payout ratio from 30% to 50% of net income. The company has also finalized a lithium joint venture with Chilean state miner Codelco, focused on lithium operations. Sociedad Química y Minera de Chile, or SQM, is a Chile based chemicals and mining company with a major focus on lithium for battery production, along with other specialty fertilizers and industrial chemicals. The combination of a higher proposed...
NYSE:BAP
NYSE:BAPBanks

Credicorp (NYSE:BAP) Margins Improve To 33.5% Reinforcing Bullish Earnings Narratives

Credicorp (NYSE:BAP) has just posted another set of quarterly numbers that keep the focus on earnings power, with Q4 2025 revenue at S/5.4 billion and basic EPS of S/19.9 alongside net income of S/1.6 billion. Over the past few quarters, revenue has moved from S/4.6 billion in Q3 2024 to S/5.1 billion in Q4 2024 and then to S/5.4 billion in Q4 2025. Quarterly EPS shifted from S/14.0 to S/22.4 at the start of 2025 before landing at S/19.9 in the latest period, highlighting trailing earnings...
NYSE:PNFP
NYSE:PNFPBanks

Pinnacle Synovus Merger Expands Scale And Puts Security In Focus

Pinnacle Financial Partners (NYSE:PNFP) has completed its merger with Synovus Financial Corp., creating a regional bank with over US$120b in assets. The combined bank now operates on a new shared platform serving customers across the southeastern U.S. Following the merger, Douglas Hromco has been appointed chief security officer to oversee cybersecurity, fraud prevention, and physical security for the enlarged organization. For you as an investor, this deal moves NYSE:PNFP further into the...
NYSE:TRAK
NYSE:TRAKSoftware

ReposiTrak (TRAK) Q3 Net Margin Near 30% Tests Bullish Profitability Narrative

ReposiTrak (TRAK) has reported Q3 2026 revenue of about US$5.9 million with basic EPS of roughly US$0.11, against a trailing 12 month EPS figure of about US$0.39 that reflects earnings growth of 11.5% over the past year and 17% per year over five years. Over recent quarters, the company has seen revenue move around the US$5.5 million to US$6.0 million range while quarterly EPS has tracked between roughly US$0.08 and US$0.11, supported by trailing 12 month net income of about US$7.1 million...
NYSE:WEX
NYSE:WEXDiversified Financial

WEX Buyback Board Reset And EV Partnership Reshape Growth Priorities

WEX (NYSE:WEX) has authorized a new $1b share repurchase program. The company has appointed David Foss as independent Chair, separating the Chair and CEO roles. WEX has reached a cooperation agreement with Impactive Capital that includes new board appointments and governance changes. The company has entered a partnership with Electric Era to expand fleet payment access to EV charging locations across the US. WEX, trading at $141.42, sits at the center of several material corporate decisions...
NYSE:SNDR
NYSE:SNDRTransportation

Schneider National ESOP Shelf Sparks Questions On Dilution And Valuation Gap

Schneider National (NYSE:SNDR) filed a shelf registration for an Employee Stock Ownership Plan related offering of approximately 19.9 million Class B shares. The filing covers up to US$610 million of securities that may be offered from time to time. The move centers on Class B common stock that is linked to employee ownership and incentive structures. Schneider National is a large North American trucking, intermodal, and logistics company, so any change in its equity structure tends to draw...
NasdaqGS:PYXS
NasdaqGS:PYXSBiotechs

Pyxis Oncology (PYXS) Cash Runway Under One Year Reinforces Bearish Funding Narratives

Pyxis Oncology (PYXS) has opened 2026 with Q1 results that keep the focus on scaling the top line while absorbing ongoing losses, with trailing 12 month revenue at about US$13.9 million and a basic EPS loss of roughly US$1.28 alongside net income losses of about US$79.6 million. Over recent quarters, the company has seen revenue move from US$0 in Q1 2025 to US$11.0 million in Q4 2025, while quarterly basic EPS losses have ranged between about US$0.29 and US$0.35 per share. For investors, that...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Is It Too Late To Consider Golar LNG (GLNG) After A 50% Year-To-Date Surge?

Many investors are considering whether Golar LNG is fairly priced at its current level, or whether the stock still offers value for new money going in. The stock last closed at US$57.04, with returns of 2.4% over the past week, 6.0% over the past month, 50.3% year to date and 47.9% over the past year. These moves may have influenced how investors view its potential and risk. Recent coverage has focused on Golar LNG's positioning within the energy sector and on how investors are reacting to...
NasdaqCM:RCEL
NasdaqCM:RCELBiotechs

Avita Medical (RCEL) Q1 Loss Of US$0.35 Per Share Tests Profitability Optimism

AVITA Medical (NasdaqCM:RCEL) opened Q1 2026 with revenue of US$19.3 million and a basic EPS loss of US$0.35, while trailing twelve month figures show revenue of US$72.3 million and a basic EPS loss of US$1.57. The company has seen quarterly revenue move from US$18.5 million in Q1 2025 to US$19.3 million in Q1 2026, alongside quarterly EPS losses shifting from US$0.53 to US$0.35. This keeps the focus firmly on how quickly margins can tighten and losses can be contained. See our full analysis...
NYSE:BOC
NYSE:BOCMedia

Boston Omaha (BOC) TTM Losses Deepen And Reinforce Bearish Earnings Narratives

Boston Omaha (BOC) opened 2026 with Q1 revenue of about US$28.2 million and a basic EPS loss of US$0.07, alongside a trailing 12 month EPS loss of US$0.44 on revenue of roughly US$114.9 million. This keeps the stock in loss making territory at a share price of US$11.06. Over the past six quarters, revenue has moved in a tight band between roughly US$27.7 million and US$29.7 million per quarter, while quarterly basic EPS has ranged from a profit of US$0.17 to a loss of US$0.22. This points to...